Our Story
Increase the Certainty of Drug Development Success
The drug discovery and development process is complex, with more failures than successes. As your trusted partner, we accelerate medicines to patients, using biosimulation (modeling and simulation) and technology-enabled services to transform drug discovery and development.
Our integrated and proprietary end-to-end platform with generative AI technology, biosimulation, regulatory science, and market access solutions combined with our global 1,400+ strong team of scientists and experts enable informed decision-making, higher R&D productivity, and improved patient outcomes. With our quantitative approach, we anticipate and address your critical drug discovery and development decisions:
- How can dosing be optimized to maximize safety and efficacy?
- What is the probability of clinical trial success?
- How do we work with regulatory agencies to steer through uncertainty?
- What’s the best way to assess and demonstrate the maximum value of a new therapy?
Certara works across all therapeutic areas and innovative therapies, including immuno-oncology, rare disease, CNS, respiratory disease, gene therapy, and global health, providing translational solutions from discovery to patient access.
Certara’s End-to-End Platform
>90%
of new drug approvals by the FDA were received by our customers in the past 9 years
300+
global regulatory and health authority submissions were prepared and delivered in the past 5 years
60,000+
drug developers are end-users worldwide
Our History
In 2008, Tripos International and Pharsight Corporation came together to form Certara. Since then, we have achieved incredible growth through acquisitions and the pharmaceutical industry and regulatory agencies’ adoption of model-informed drug development (MIDD).
Today, we are the global leader in biosimulation.
We can help you go farther, faster. Wherever you are in your drug development journey, Certara can help you improve decision-making.
Image Credit: JUSTIN LANE/EPA-EFE/Shutterstock
Unmatched MIDD Expertise at Scale
The high quality of our work is the result of dedication, collaboration, and deep expertise.
With Certara, your partners are experts who are committed to finding the right answers and increasing the probability of your success.
We navigate complexity through flawless execution and stewardship with our top scientists and experts in pursuit of your goals.
Customers First Focus
Your success is our guiding principle. Trusted by more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries, we are members of your team.
We design and implement drug development strategies using quantitative science and an integrated approach to:
- Get to proof of concept faster
- Optimize trial design
- Reduce trial size or avoid certain trials altogether
- Expedite regulatory submissions
- Expand patient access to medicines
Recognized as an Employer of Choice
We foster a culture of excellence that is reflected in our reputation and achievement. For two years in a row, Certara has been Certified as a Great Place to Work. In fact, 88% of Certara employees say it is a great place to work compared to 57% of employees at a typical U.S.-based company.
How can Certara help you?
Start a conversation with us
